Biotech Stocks: 5 Best Performing So Far This Year #janssen #pharma

Posted On Jul 13 2017 by

#biotech companies # The 5 Best Performing Biotech Stocks in 2016 Biotechnology stocks had a rough start to the year. Although there was an overall market slump. biotech stocks nonetheless had a much rougher ride. and the sector still hasn t quite recovered. The Nasdaq biotechnology index is down over 22% year-to-date. In comparison, the Standard Poor s 500 Index, a measure of overall market performance, is down by only 1% for the year. However, there are a handful of biotech companies that have managed to buck the trend. They ve posted positive returns—with true breakthroughs. Here s a look …


Biotech Stocks: 5 Best Performing So Far This Year #pharmaceutical #manufacturers #association

Posted On May 20 2017 by

#biotech companies # The 5 Best Performing Biotech Stocks in 2016 Biotechnology stocks had a rough start to the year. Although there was an overall market slump. biotech stocks nonetheless had a much rougher ride. and the sector still hasn t quite recovered. The Nasdaq biotechnology index is down over 22% year-to-date. In comparison, the Standard Poor s 500 Index, a measure of overall market performance, is down by only 1% for the year. However, there are a handful of biotech companies that have managed to buck the trend. They ve posted positive returns—with true breakthroughs. Here s a look …


The year s top pharma marketing controversies – Medical Marketing and Media #pharma #agencies

Posted On May 15 2017 by

#marketing pharmaceuticals # December 23, 2015 The year’s top pharma marketing controversies Photo credit: Bill Brooks/Creative Commons 1. Drug pricing goes public: In the past year, what was once an issue debated among few stakeholders in the medical community became a talking point in presidential campaigns. (Bill Clinton’s words of advice to pharma: “Explain, explain, explain; disclose, disclose, disclose.”) The issue of how and why drugs are priced the way they are hit a tipping point, as insurers, pharmacy benefit managers, physicians and even presumptive presidential candidates questioned pharmaceutical pricing practices and called for changes to the current system. 2. …


Biotech Stocks: 5 Best Performing So Far This Year #uk #pharma

Posted On Apr 15 2017 by

#biotech companies # The 5 Best Performing Biotech Stocks in 2016 Biotechnology stocks had a rough start to the year. Although there was an overall market slump. biotech stocks nonetheless had a much rougher ride. and the sector still hasn t quite recovered. The Nasdaq biotechnology index is down over 22% year-to-date. In comparison, the Standard Poor s 500 Index, a measure of overall market performance, is down by only 1% for the year. However, there are a handful of biotech companies that have managed to buck the trend. They ve posted positive returns—with true breakthroughs. Here s a look …


The year s top pharma marketing controversies – Medical Marketing and Media #fda #and #pharmaceutical

Posted On Dec 9 2016 by

#marketing pharmaceuticals # December 23, 2015 The year’s top pharma marketing controversies Photo credit: Bill Brooks/Creative Commons 1. Drug pricing goes public: In the past year, what was once an issue debated among few stakeholders in the medical community became a talking point in presidential campaigns. (Bill Clinton’s words of advice to pharma: “Explain, explain, explain; disclose, disclose, disclose.”) The issue of how and why drugs are priced the way they are hit a tipping point, as insurers, pharmacy benefit managers, physicians and even presumptive presidential candidates questioned pharmaceutical pricing practices and called for changes to the current system. 2. …


Biotech Stocks: 5 Best Performing So Far This Year #idm #pharma

Posted On Nov 17 2016 by

#biotech companies # The 5 Best Performing Biotech Stocks in 2016 Biotechnology stocks had a rough start to the year. Although there was an overall market slump. biotech stocks nonetheless had a much rougher ride. and the sector still hasn t quite recovered. The Nasdaq biotechnology index is down over 22% year-to-date. In comparison, the Standard Poor s 500 Index, a measure of overall market performance, is down by only 1% for the year. However, there are a handful of biotech companies that have managed to buck the trend. They ve posted positive returns—with true breakthroughs. Here s a look …


The year s top pharma marketing controversies – Medical Marketing and Media #exl #pharma

Posted On Nov 12 2016 by

#marketing pharmaceuticals # December 23, 2015 The year’s top pharma marketing controversies Photo credit: Bill Brooks/Creative Commons 1. Drug pricing goes public: In the past year, what was once an issue debated among few stakeholders in the medical community became a talking point in presidential campaigns. (Bill Clinton’s words of advice to pharma: “Explain, explain, explain; disclose, disclose, disclose.”) The issue of how and why drugs are priced the way they are hit a tipping point, as insurers, pharmacy benefit managers, physicians and even presumptive presidential candidates questioned pharmaceutical pricing practices and called for changes to the current system. 2. …


The year s top pharma marketing controversies – Medical Marketing and Media #i3 #pharma #resourcing

Posted On Nov 4 2016 by

#marketing pharmaceuticals # December 23, 2015 The year’s top pharma marketing controversies Photo credit: Bill Brooks/Creative Commons 1. Drug pricing goes public: In the past year, what was once an issue debated among few stakeholders in the medical community became a talking point in presidential campaigns. (Bill Clinton’s words of advice to pharma: “Explain, explain, explain; disclose, disclose, disclose.”) The issue of how and why drugs are priced the way they are hit a tipping point, as insurers, pharmacy benefit managers, physicians and even presumptive presidential candidates questioned pharmaceutical pricing practices and called for changes to the current system. 2. …


Biotech Stocks: 5 Best Performing So Far This Year #medical #sales #jobs

Posted On Oct 31 2016 by

#biotech companies # The 5 Best Performing Biotech Stocks in 2016 Biotechnology stocks had a rough start to the year. Although there was an overall market slump. biotech stocks nonetheless had a much rougher ride. and the sector still hasn t quite recovered. The Nasdaq biotechnology index is down over 22% year-to-date. In comparison, the Standard Poor s 500 Index, a measure of overall market performance, is down by only 1% for the year. However, there are a handful of biotech companies that have managed to buck the trend. They ve posted positive returns—with true breakthroughs. Here s a look …


Biotech Stocks: 5 Best Performing So Far This Year #purdue #pharmaceuticals

Posted On Oct 24 2016 by

#biotech companies # The 5 Best Performing Biotech Stocks in 2016 Biotechnology stocks had a rough start to the year. Although there was an overall market slump. biotech stocks nonetheless had a much rougher ride. and the sector still hasn t quite recovered. The Nasdaq biotechnology index is down over 22% year-to-date. In comparison, the Standard Poor s 500 Index, a measure of overall market performance, is down by only 1% for the year. However, there are a handful of biotech companies that have managed to buck the trend. They ve posted positive returns—with true breakthroughs. Here s a look …